Can Stem Cells Help Chronic Obstructive Pulmonary Disorder?

What is Chronic Obstructive Pulmonary Disorder?

Chronic Obstructive Pulmonary Disorder (COPD) is a distressing lung disease and worsens quickly without proper treatment and symptom control. There are four stages of development for chronic obstructive pulmonary disorder, starting with mild and ending with very severe. Airflow is restricted from easily moving in and out of the lungs, this dysfunction characterizes the disease. Chronic obstructive pulmonary disorder is the canopy term for patients who have been diagnosed with or show indications of emphysema and/or chronic bronchitisStem cell therapies for chronic obstructive pulmonary disorder are emerging as practical options for people suffering from this condition.

Therapies for Chronic Obstructive Pulmonary Disorder

There isn’t a known cure for chronic obstructive pulmonary disorder, but that does not mean that you cannot treat the disease. Many doctors recommend bronchodilators to help open the airways to allow for an increase in airflow. Also, it is typical that a chronic obstructive pulmonary disorder treatment plan to contain a series of breathing and aerobic exercise to improve some pulmonary functioning. For people in the most severe end stage of chronic obstructive pulmonary disorder, supplemental oxygen is also suggested for treatment. Although most of these therapies are supportive, they do not contribute in the reversal of any symptoms, they are used however, to stop the further progression of chronic obstructive pulmonary disorder. A group of innovative physicians have revealed in the recent past that the use of stem cells can have a positive effect in treating chronic obstructive pulmonary disorder and other lung diseases.

What are Stem Cells? 

Stem cells are the building blocks for any type of living organism. They have the capability for self-renewal and replication, capable of forming any type of tissue or organ in your body. Adult stem cells from one organ are able to create tissue for another organ, which is termed plasticity. It has been proven that adult stem cells are able to be transferred into any one single organ in a patient’s body.

Stem Cell Therapies for Chronic Obstructive Pulmonary Disorder 

In the matter of treatment for lung diseases, autologous stem cells are administered, meaning they come from the patient’s own body, and can be extracted from patient’s venous blood. Stem cells extracted from bone marrow or blood have the ability to mold into many types of diverse cells.

Throughout the procedure, stem cell therapy involves separating adult stem cells from bone marrow, which involves specific laboratory equipment to collect them. After being removed from the patient’s body, they are isolated. They are then returned to the patient intravenously. It surprises many people to hear that the treatment is minimally invasive and typically an outpatient procedure.

These medical procedures should be performed in a clinical venue under the supervision of a trained physician. It takes a professional that has sought specific training in stem cell therapies to perform the treatment safely and proficiently.

If you would like to speak with someone to find out if you qualify for stem cell therapy for chronic obstructive pulmonary disorder, please contact one of our patient care coordinators today at (800) 729-3065 to schedule a free consultation.


* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.